Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-001 in wet Age-related Macular Degeneration
NCT06707753Phase 2Active, not recruiting
- Sponsor
- Anlong Bio
- Start
- Sep 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AL001 in exudative macular degeneration, sponsored by Anlong Bio. Started Sep 2023; status: active, not recruiting.
02
Drugs
AL001
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT06707753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06707753.